当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析

羚锐制药

(600285)

  

流通市值:133.09亿  总市值:133.39亿
流通股本:5.66亿   总股本:5.67亿

羚锐制药(600285)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.17亿元,每股收益0.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益334386.85万元,未分配利润212030.33万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产541089.58万元,负债206702.73万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,020,755,870.553,500,831,286.922,759,116,202.141,906,007,173.3
营业总成本780,335,122.232,768,148,768.852,132,955,810.671,454,748,169.02
营业利润253,684,137.59810,301,684.55662,676,665.58476,716,553.34
利润总额253,668,892.56827,572,996.86665,105,059.05479,096,650.48
净利润216,733,789.1722,584,691.99573,907,880413,114,865.4
其他综合收益6,311,122.23-52,945,072.92-49,302,213.98-56,954,231.11
综合收益总额223,044,911.33669,639,619.07524,605,666.02356,160,634.29
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,004,404,855.72,458,038,247.112,262,062,502.12,099,554,692.35
非流动资产合计3,406,490,925.222,558,804,960.622,623,500,075.952,614,416,820.84
资产总计5,410,895,780.925,016,843,207.734,885,562,578.054,713,971,513.19
流动负债合计1,986,108,168.891,874,335,175.061,917,993,701.61,939,062,284.83
非流动负债合计80,919,127.4662,215,968.6765,980,773.5163,927,964.23
负债合计2,067,027,296.351,936,551,143.731,983,974,475.112,002,990,249.06
归属于母公司股东权益合计3,311,522,505.913,072,526,287.292,893,837,629.182,703,211,333.73
股东权益合计3,343,868,484.573,080,292,0642,901,588,102.942,710,981,264.13
负债和股东权益合计5,410,895,780.925,016,843,207.734,885,562,578.054,713,971,513.19
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计903,232,099.553,924,835,712.292,656,515,780.871,835,882,538.51
经营活动现金流出小计785,616,199.433,048,971,479.162,306,466,328.621,545,283,321.58
经营活动产生的现金流量净额117,615,900.12875,864,233.13350,049,452.25290,599,216.93
投资活动现金流入小计159,012,139.42465,877,124.381,132,711,885.05513,778,335.52
投资活动现金流出小计944,785,928.441,131,709,447.721,750,214,149.761,122,842,238.19
投资活动产生的现金流量净额-785,773,789.02-665,832,323.34-617,502,264.71-609,063,902.67
筹资活动现金流入小计11,340,271.8984,193,548.6419,592,190.8325,705,891.33
筹资活动现金流出小计617,588.12556,131,430.6469,975,832.3470,622,535.02
筹资活动产生的现金流量净额10,722,683.77-471,937,881.96-450,383,641.47-444,916,643.69
汇率变动对现金及现金等价物的影响-12,982.27,770.61-3,101.422,157.48
现金及现金等价物净增加额-657,448,187.33-261,898,201.56-717,839,555.35-763,379,171.95
期末现金及现金等价物余额570,929,618.671,228,377,806772,436,452.21726,896,835.61
最新报告期:2025-06-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
首创证券王斌1.481.701.912025-06-26
东海证券杜永宏1.461.681.902025-05-13
招商证券梁广楷,欧阳京,许菲菲1.431.661.892025-05-09
兴业证券孙媛媛,董晓洁1.481.691.932025-05-02
开源证券余汝意1.471.681.892025-05-01
TOP↑